Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia

Archives of General Psychiatry

Volumn 55, Issue 3, 1998, Pages 225-232

  Arnold, Steven E ^a   Trojanowski, John Q ^a   Gur, Raquel E ^a   Blackwell, Peter ^a   Han, Li Ying ^a   Choi, Catherine ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; MICROGLIA; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; SCHIZOPHRENIA; SENILE PLAQUE; AGE; AUTOPSY; NEUROPATHOLOGY; NEUROPSYCHIATRY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGE FACTORS; AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; CEREBRAL CORTEX; COGNITION DISORDERS; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LEWY BODIES; MALE; NEUROFIBRILLARY TANGLES; NEURONS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENILE PLAQUES;

EID: 0032498818     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.3.225     Document Type: Article

References (68)

1. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: E & S Livingstone; 1919.
2. Bleuler M. A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. In: Rosenthal D, Kety SS, eds. The Transmission of Schizophrenia. New York, NY: Pergamon Press Inc; 1968:3-12.
3. Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bud. 1980;6:606-618.
4. Carpenter WT, Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull. 1988;14:515-542.
5. Winokur G, Pfohl B, Tsuang M. A 40-year follow-up of hebephremc-catatonic schizophrenia. In: Miller N, Conen G, eds. Schizophrenia and Aging. New York, NY: Guilford Press; 1987:52-60.
6. Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, Gur RC, Blackwell P, Trojanowski JO. Prospective clinicopathological studies of schizophrenia: accrual and assessment. Am J Psychiatry. 1995;152:731-737.
7. Davidson M, Harvey PD, Powchik P, Parella M, White L, Knobler HY, Losonczy MF, Keefe RSE, Katz S, Frecska E. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry. 1995:152:197-207.
8. Goldberg TE, Hyde TM, Leinman JE, Weinberger DR. Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr Bull. 1993;19:797-804.
9. Chen EY, Lam LC, Chen RY, Nguyen DG, Chan CK, Prefrontal neuropsychological impairment and illness duration in schizophrenia: a study of 204 patients in Hong Kong. Acta Psychiatr Scand. 1996;93:144-150.
10. Hyde TM, Nawroz S, Goldberg TE, Bigelow LB, Strong D, Ostrem JL, Weinberger DR, Kleinman JE. Is there cognitive decline in schizophrenia? a cross-sectional study. Br J Psychiatry. 1994;164:494-500.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
12. Moberg PJ, Mahr R, Gibney M, Arnold SE, Shapiro R, Kumar A, Gottlieb G, Gur RE. Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. J Int Neuropsychol Soc. 1995;1:132. Abstract.
13. Arnold SE, Franz BR, Trojanowski JQ. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging. 1994;15:299-303.
14. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonezy M, McCrystal J, Purohit DP, Bierer LM, Davis KL. Cortical cholinergic markers in schizophrenia. Schizophr Res. 1994;12:137-144.
15. Purohit DP, Dawdson M, Perl DP, Powchick P, Haroutunian VH, Bierer LM, McCrystal J, Losonsczy M, Davis KL. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry. 1993;33:255-260.
16. Larson EB, Reifler BV, Featherstone HJ, English DR. Dementia in elderly outpatients: a prospective study. Ann Intern Med. 1984;100:417-423.
17. Tomlinson BE. Ageing and the dementias. In: Adams JH, Duchen LW, eds. Greenfield's Neuropathology. 5th ed. New York, NY: Oxford University Press Inc; 1992:1284-1410.
18. Lowe J. Lewy bodies. In: Calne DB, ed. Neurodegenerative Diseases. Philadelphia, Pa: WB Saunders Co; 1993:51-69.
19. Duchen LW. General pathology of neurons and neuroglia. In: Adams JH, Duchen LW, eds. Greenfield's Neuropathology, 5th ed. New York, NY: Oxford University Press Inc; 1992:1-68.
20. Lowe J, Mayer RJ, Landen M. Ubiquitin in neurodegenerative diseases. Brain Pathol 1993;3:55-65.
21. Nakajima K, Kohsaka S. Functional roles of microglia in the brain. Neurosci Res. 1993;17:187-203.
22. Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
24. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa: The University of Iowa; 1984.
25. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: The University of Iowa; 1983.
26. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Dept of Health, Education and Welfare; 1976. US Dept of Health, Education and Welfare publication ADM76-338.
27. Lawton MP, Brody EM. Physical Self-Maintenance Scale (Functional Assessment). Gerontologist 1969;9:179-186.
28. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
29. Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA. 1990;87:5827-5831.
30. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. An extensive network of PHF-t-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett. 1994;344:69-73.
31. Schmidt ML, Murray J, Lee VM-Y, Hill WD, Wertkin A, Trojanowski JQ. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol. 1991;139:53-65.
32. Trojanowski JQ, Gordon D, Obrocka M, Lee VM-Y. The developmental expression of neurofilament and glial filament proteins in the human pituitary gland: an immunohistochemical study with monoclonal antibodies. Dev Brain Res. 1984;13:229-239.
33. Arai H, Lee VM-Y, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol. 1991;30:686-693.
34. Amaral DG, Insausti R. Hippocampal formation. In: Paxinos G, ed. The Human Nervous System. San Diego, Calif: Academic Press Inc; 1990:711-755.
35. Insausti R, Tunon T, Sobreviela T, Insausti AM, Gonzalo LM. The human entorhinal cortex: a cytoarchitectonic analysis. J Comp Neurol. 1995;355:171-198.
36. Arnold SE, Hyman BT, Flory J, Damasio AR, Hoesen GWV. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1991;1:103-116.
37. Rajkowska G, Goldman-Rakic PS. Cytoarchitectonic definition of prefrontal areas in the normal human cortex, I: remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex. 1995;5:307-322.
38. Arnold SE. Cellular and molecular pathology of the frontal lobe dementias, In: Trojanowski JQ, Clark CM, eds, Neurodegenerative Dementia: Clinical and Pathological Mechanisms. New York, NY: McGraw-Hill Book Co. In press.
39. Garey U. Visual system. In: Paxinos G, eo. The Human Nervous System. San Diego, Calif: Academic Press Inc; 1990:945-977.
40. West MJ. New stereological methods for counting neurons. Neurobiol Aging. 1993;14:287-293.
41. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JN, Pakkenberg B, Sorenson FB, Vesterby A, West MJ. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988;96:379-394.
42. Mann DMA. Vulnerability of specific neurons to aging. In: Calne DB, ed. Neurodegenerative Diseases. Philadelphia, Pa; WB Saunders Co; 1994:15-31.
43. Gur RE, Pearlson GD. Neuroimaging in schizophrenia research. Schizophr Bull. 1993;19:337-353.
44. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol. 1996;92:217-231.
45. Buhl L, Bojsen-Moller M. Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan Med Bull. 1988;35:288-290.
46. Prohovnik I, Dwork AJ, Kaufman MA, Wilson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull. 1993;19:805-816.
47. Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DGC, Roberts GW. Schizophrenia and the braIn: a prospective clinico-neuropathological study. Psychol Med. 1990;20:285-304.
48. Powchik P, Davidson M, Nemeroff CB, Haroutunian V, Purohit OP, Losonczy M, Bissette G, Perl D, Ghanbari H, Miller B, Davis K. Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment. Am J Psychiatry. 1993;150:1726-1727.
49. Stevens JR. Neuropathology of schizophrenia. Arch Gen Psychiatry. 1982;39:1131-1139.
50. Arnold SE, Franz BR, Trojanoivsky JQ, Moberg PJ, Gur RE, Glial fibrillary acidic protein immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol. 1996;91:269-277.
51. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986;43:31-35.
52. Falkai P, Bogerts B, Rozumek M. Limbic pathology in schizophrenia: the entorhinal region, a morpbometric study. Biol Psychiatry. 1988;24:515-521.
53. Roberts GW, Colter N, Lofthouse R, Johnstone EC, Crow TJ. Is there gliosis in schizophrenia? investigation of the temporal lobe. Biol Psychiatry. 1987;22:1459-1468.
54. Stevens CD, Altshuler LL, Bogerts B, Falkai P. Quantitative study of gliosis in schizophrenia and Huntington's chorea. Biol Psychiatry. 1988;24:697-700.
55. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52:805-818.
56. Stevens JR, Casanova M, Poltorak M, Germain L, Buchan GC. Comparison of immunocytochemical and Holzer's methods for detection of acute chronic gliosis in human postmortem material. J Neuropsychiatry Clin Neurosci. 1992;4:168-173.
57. Horton K, Forsyth CS, Sibtain N, Ball S, Bruton CJ, Royston MC, Roberts GW. Ubiquitination as a probe for neurodegeneration in the brain in schizophrenia: the prefrontal cortex. Psychiatry Res. 1993;48:145-152.
58. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reging H, Yen S-H. Ubiquitin-immunoreactive structures in normal brains: distribution and developmental aspects. Lab Invest. 1990;63:87-99.
59. Ganguli R, Zang Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, Rabin BS. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res. 1994;51:1-10.
60. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL. Increases in CSF levels of IL-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry. 1995;152:1291-1297.
61. Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, Rabin BS. Mitogen-stimulated interleukin-2 production in never-medicated first-episode schizophrenic patients: the influence of age at onset and negative symptoms. Arch Gen Psychiatry. 1995;52:668-672.
62. Arnold SE, Hyman BT, Hoesen GWV, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry. 1991;48:625-632.
63. Arnold SE, Han L-Y, Ruscheinsky DD. Further evidence of cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry. 1997;42:639-647.
64. Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm. 1986;65:303-326.
65. Krimer LS, Herman MM, Saunders RC, Boyd JC, Kleinman JE, Hyde TM, Weinberger DR. Qualitative and quantitative analysis of the entorhinal cortex cyto-architectural organization in schizophrenia. Soc Neurosci Abstr. 1995;21:239.
66. Longson D, Deakin JFW, Benes FM. Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia. J Neural Transm. 1996;103:503-507.
67. Akil M, Lewis DA. The catecholaminergic innervation of the human entorhinal cortex: alterations in schizophrenia. Soc Neurosci Abstr. 1995;21:238.
68. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239-259.